Clinical Trails

 In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behaviour, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. Preclinical trials are early experiments performed in the lab, prior to being tested in humans. This early research helps to identify potential treatments that are unsafe or ineffective. Clinical trials used in drug development are sometimes described by phase. These phases are defined by the Food and Drug Administration (FDA).

 

  • Pre-clinical Studies

Related Conference of Clinical Trails

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
July 23-24, 2026

22nd World Congress on Structural Biology

Aix-en-Provence, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain

Clinical Trails Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in